Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Neurovascular function in Alzheimer's disease patients and experimental models.

Nicolakakis N, Hamel E.

J Cereb Blood Flow Metab. 2011 Jun;31(6):1354-70. doi: 10.1038/jcbfm.2011.43. Epub 2011 Apr 6. Review.

2.

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

Bell RD, Zlokovic BV.

Acta Neuropathol. 2009 Jul;118(1):103-13. doi: 10.1007/s00401-009-0522-3. Epub 2009 Mar 25. Review.

3.

Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.

Sagare AP, Bell RD, Zlokovic BV.

Cold Spring Harb Perspect Med. 2012 Oct 1;2(10). pii: a011452. doi: 10.1101/cshperspect.a011452. Review.

4.

Neurovascular mechanisms of Alzheimer's neurodegeneration.

Zlokovic BV.

Trends Neurosci. 2005 Apr;28(4):202-8. Review.

PMID:
15808355
5.

New therapeutic targets in the neurovascular pathway in Alzheimer's disease.

Zlokovic BV.

Neurotherapeutics. 2008 Jul;5(3):409-14. doi: 10.1016/j.nurt.2008.05.011. Review.

6.

Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.

Sagare AP, Bell RD, Zlokovic BV.

J Alzheimers Dis. 2013;33 Suppl 1:S87-100. Review.

7.

The role of perivascular innervation and neurally mediated vasoreactivity in the pathophysiology of Alzheimer's disease.

Nizari S, Romero IA, Hawkes CA.

Clin Sci (Lond). 2017 Jun 1;131(12):1207-1214. doi: 10.1042/CS20160769. Review.

PMID:
28566449
8.

Cerebral autoregulation in Alzheimer's disease.

Claassen JA, Zhang R.

J Cereb Blood Flow Metab. 2011 Jul;31(7):1572-7. doi: 10.1038/jcbfm.2011.69. Epub 2011 May 4. Review.

9.

The cerebrovascular role of the cholinergic neural system in Alzheimer's disease.

Van Beek AH, Claassen JA.

Behav Brain Res. 2011 Aug 10;221(2):537-42. doi: 10.1016/j.bbr.2009.12.047. Epub 2010 Jan 7. Review.

PMID:
20060023
10.

Critically attained threshold of cerebral hypoperfusion: can it cause Alzheimer's disease?

de la Torre JC.

Ann N Y Acad Sci. 2000 Apr;903:424-36. Review.

PMID:
10818533
11.

Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy.

Hamel E, Royea J, Ongali B, Tong XK.

Cell Mol Neurobiol. 2016 Mar;36(2):219-32. doi: 10.1007/s10571-015-0285-4. Epub 2016 Mar 18. Review.

PMID:
26993506
12.

Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.

Deane R, Zlokovic BV.

Curr Alzheimer Res. 2007 Apr;4(2):191-7. Review.

PMID:
17430246
13.
14.

Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide.

de la Torre JC, Stefano GB.

Brain Res Brain Res Rev. 2000 Dec;34(3):119-36. Review.

PMID:
11113503
15.

Cerebrovascular contributions to Alzheimer's disease pathophysiology and potential therapeutic interventions in mouse models.

Thomason LA, Stefanovic B, McLaurin J.

Eur J Neurosci. 2013 Jun;37(12):1994-2004. doi: 10.1111/ejn.12181. Review.

PMID:
23773069
16.

Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations.

Koizumi K, Wang G, Park L.

Cell Mol Neurobiol. 2016 Mar;36(2):155-65. doi: 10.1007/s10571-015-0256-9. Epub 2015 Sep 2. Review.

17.

Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.

Kisler K, Nelson AR, Montagne A, Zlokovic BV.

Nat Rev Neurosci. 2017 Jul;18(7):419-434. doi: 10.1038/nrn.2017.48. Epub 2017 May 18. Review.

18.
19.
20.

The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease.

Kalaria RN.

Ann N Y Acad Sci. 1999;893:113-25. Review.

PMID:
10672233

Supplemental Content

Support Center